Kinnate Biopharma Inc.
Kinnate Biopharma Inc. (KNTE) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 117 transactions totaling $79.8M, demonstrating a bullish sentiment with $79.8M in net insider flow. The most recent transaction on Apr 3, 2024 involved a transaction of 9,671,643 shares valued at $0.
KNTE Insider Activity Summary
Who Is Buying KNTE Stock?
No significant insider buying has been recorded for KNTE in the recent period.
Who Is Selling KNTE Stock?
No significant insider selling has been recorded for KNTE in the recent period.
Is Kinnate Biopharma Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KNTE is bullish with an Insider Alignment Score of 100/100 and a net flow of $79.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KNTE Frequently Asked Questions
Understanding KNTE Insider Activity
Insider trading at Kinnate Biopharma Inc. (KNTE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading KNTE stock, having executed 117 transactions in the past 90 days. The most active insider is James B. Tananbaum (Executive), who has made 12 transactions totaling $25.0M.
Related Tools
Track Kinnate Biopharma Inc. Insider Activity
Get notified when executives and directors at KNTE file new Form 4 transactions